D.E. Shaw & Co
CLVS

D.E. Shaw & Co’s Clovis Oncology, Inc. CLVS Stock Holding History

D.E. Shaw & Co’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100,000
Closed -$1.04M – 4376
2019
Q4 		$1.04M Hold
100,000
– – ﹤0.01% 2955
2019
Q3 		$393K Buy
100,000
+87,600
+706% +$709K ﹤0.01% 3327
2019
Q2 		$184K Hold
12,400
– – ﹤0.01% 3483
2019
Q1 		$308K Sell
12,400
-15,200
-55% -$381K ﹤0.01% 3206
2018
Q4 		$496K Buy
27,600
+7,100
+35% +$145K ﹤0.01% 3094
2018
Q3 		$602K Hold
20,500
– – ﹤0.01% 2999
2018
Q2 		$932K Sell
20,500
-14,500
-41% -$705K ﹤0.01% 2740
2018
Q1 		$1.85M Sell
35,000
-3,700
-10% -$216K ﹤0.01% 2104
2017
Q4 		$2.63M Buy
38,700
+8,700
+29% +$608K ﹤0.01% 1929
2017
Q3 		$2.47M Buy
30,000
+10,000
+50% +$793K ﹤0.01% 1874
2017
Q2 		$1.87M Hold
20,000
– – ﹤0.01% 2017
2017
Q1 		$1.27M Buy
20,000
+9,600
+92% +$584K ﹤0.01% 2149
2016
Q4 		$462K Buy
+10,400
New +$366K ﹤0.01% 2890
2015
Q4 		– Sell
-20,200
Closed -$1.86M – 4024
2015
Q3 		$1.86M Buy
+20,200
New +$1.75M ﹤0.01% 2155
2015
Q2 		– Sell
-10,000
Closed -$742K – 3922
2015
Q1 		$742K Buy
+10,000
New +$706K ﹤0.01% 2784

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

D.E. Shaw & Co's CLVS Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 44,924 shares — an estimated $53K sold.

D.E. Shaw & Co first reported a position in CLVS in Q2 2013 and held it in 35 quarters. The position peaked at $104M in Q1 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 44,924 Clovis Oncology, Inc. shares in Q4 2022, an estimated $53K.
  • D.E. Shaw & Co first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 35 quarters.
  • D.E. Shaw & Co's Clovis Oncology, Inc. position peaked at $104M in Q1 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.